top of page

CASE STUDIES

Case Study 1: Enhancing the Effectiveness of a Field Medical Organization in a Mid-Size Pharmaceutical Company

Challenge

  • Inconsistent KPIs across therapeutic area MSL teams

  • Limited recognition of MSL value by internal stakeholders

  • Role confusion within Medical Affairs

  • Feedback and performance measurement reactive and unclear

​

Our Strategic Approach

  1. Conducted stakeholder interviews & cross-functional workshops

  2. Developed MSL goal-setting framework aligned with brand strategy

  3. Introduced KPI structure and upgraded reporting tools 

​

Impact

   ✔ Aligned MSL goals with product/brand strategy
   ✔ Defined clear performance metrics and impact indicators
   ✔ Improved internal visibility via enhanced dashboards
   ✔ Increased engagement and accountability among MSLs

Case Study 2: Effective Insights Gathering from KOLs through Scientific Advisory Board Meetings

Challenge / Situation

  • A small biotech company faced several high-stakes decisions regarding:

  • Phase III clinical trial design for a new indication

  • Regulatory strategy

  • Launch planning

While the company had previously relied on feedback from a consistent group of KOLs, concerns arose about potential bias due to their long-standing relationships with the organization. Additionally, the company had a limited budget but needed to gather robust, high-quality input across multiple strategic areas in a short time.


Solution & Strategic Approach
To address these challenges, we designed and executed a phased engagement strategy:

  • Curated a new cohort of KOLs with diverse backgrounds, relevant expertise, and experience in clinical development, regulatory strategy, and product launches to ensure fresh, unbiased perspectives.

  • Planned and facilitated a series of three advisory board meetings:

  • Two virtual sessions and one in-person meeting

  • Structured to allow for iterative refinement of insights and strategy

  • Collaborated closely with the client and meeting chair to:

       -Develop tailored agendas focused on key strategic questions
       -Create pre-read materials and presentations
       -Draft detailed discussion guides to ensure focused feedback on all priority areas

  • Provided full logistical support for the in-person meeting, including travel, accommodations, venue setup, catering, and on-site coordination to ensure a seamless experience for all participants

Results & Impact

  • The first virtual meeting helped frame initial thinking and surface early recommendations.

  • The second virtual session allowed for deeper discussion and refinement of strategic direction.

  • The in-person meeting enabled rich discussion, diverse input, and consensus-building, with every participant having an opportunity to share detailed recommendations.

  • Outcome: A comprehensive strategic plan for the new indication of Product X, focused on optimizing regulatory success, reimbursement potential, and commercial uptake.

  • Delivered a detailed advisory board report with an executive summary, synthesis of key insights, and clearly defined next steps for development and launch.

Case Study 3: Development of an Integrated Medical Affairs Plan (iMAP) – Pre - Launch

Challenge / Situation
A newly formed Medical Affairs team required a comprehensive, cross-functional strategic plan to guide activities during the critical pre-launch period—one year ahead of the PDUFA date, with Phase III data still pending. While a Situation Analysis and preliminary Strategic Objectives (from Commercial) were in place, the Medical Affairs function lacked:

  • A defined Medical Strategy aligned with broader business goals

  • A Scientific Communication Strategy

  • A Medical Education Plan

  • Stakeholder Engagement strategy

These missing components were crucial to informing operations and budget planning.


Solution & Approach
To build a fully integrated and actionable iMAP, the following steps were undertaken:

  • Strategic Alignment & Planning

    - Facilitated cross-functional workshops to define Medical Affairs strategic pillars in
alignment with the commercial strategy.

    -Revised and expanded the Scientific Platform to uncover evidence gaps and ensure
alignment with the medical narrative.

  • Stakeholder Mapping & Engagement

    -Identified and prioritized key external stakeholders (e.g., KOLs, guideline contributors).
    -Developed and implemented engagement plans, including targeted advisory boards to:
    1. Validate product positioning and role in the treatment landscape.
    2. Review available scientific evidence and identify data gaps to inform
    the Evidence Generation plan and future Medical Education activities.

​

Scientific Communication Development

  • Built a comprehensive Scientific Platform including lexicon, key messages, and

evidence summaries.

  • Created the Scientific Communication Plan to guide both Medical and Commercial

messaging.

  • Supported development of promotional materials by providing aligned scientific

content.

​

Internal Readiness & Education

  • Designed and delivered training for both Medical and Commercial teams focused on:

       -Disease state education
       -Product mechanism of action
       -Deep dives into current scientific evidence

​

Results & Impact

  • Successfully completed and delivered the full iMAP, including:

      -Scientific Communication Strategy & Platform
      -Medical Education Plan
      -Stakeholder Engagement Strategy

  • Enhanced cross-functional alignment, ensuring that Medical, Clinical, and Commercial

       strategies were integrated and business-aligned.

  • Established tactical action plans for the Medical Affairs team—especially Field

       Medical—mapped to each strategic pillar.

  • Enabled timely launch readiness, with Medical Affairs well-prepared to support scientific engagement, education, and communications.

bottom of page